Analytical Data
-
Gene name
EGR4
- Application
-
Alternative Names
NGFI-C; PAT133
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9WUF2
-
Expression Region
Ala231~Ser474
-
Molecular Weight
33kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EGR4 (Early Growth Response Protein 4) is a member of the EGR family of transcription factors, playing a pivotal role in various physiological and pathological processes, including neuronal development, synaptic plasticity, and tumorigenesis. The expression of EGR4 is tightly regulated, with its activity influenced by numerous stimuli such as growth factors and neural activity. Disruptions in EGR4 expression or function have been implicated in several neurodegenerative diseases and cancers, making it a significant target for therapeutic intervention. Researchers have increasingly focused on the recombinant expression of EGR4 to understand its biological functions more deeply and explore its potential as a biomarker or therapeutic target. Advances in molecular cloning and protein expression technologies have facilitated the production of EGR4 recombinant proteins, allowing for detailed studies on its structure, interaction with DNA, and modulation of downstream gene expression. Understanding the function of EGR4 at a molecular level is essential for elucidating its role in health and disease, as well as for the development of novel treatment strategies that could leverage its activities in various cellular contexts. The study of EGR4 recombinant proteins is thus a crucial step towards unraveling its complex biology and therapeutic potential.
